03 January 2019 10:15 CET

Karo Intressenter AB publishes supplement to offer document regarding its public cash offer to the shareholders in Karo Pharma Aktiebolag

#EQT VIII #Karo Pharma

Fore more information, click here.

Latest news

28 November 2022
EQT Infrastructure enters exclusive negotiations to acquire a majority stake in Trescal, a global leader in calibration laboratories
22 November 2022
EQT AB’s Nomination Committee for the Annual Shareholders’ Meeting 2023
22 November 2022
Karo Intressenter AB announces final outcome of the public cash offer to the shareholders in Karo Pharma Aktiebolag
09 November 2022
EQT Ventures III closes Europe's largest venture capital fund committed to early-stage tech startups
08 November 2022
EQT strengthens and diversifies its management team with key leadership appointments